About Liana Billings, MD
Liana Billings, MD, an endocrinologist and clinical researcher at Endeavor Health, specializes in diabetes care and cardiometabolic disease. She serves as Vice Chair of Research for the Department of Medicine and directs the Clinical and Genetics Research Program in Diabetes and Cardiometabolic Disease. Dr. Billings focuses on precision medicine to better understand how genetics influence diagnosis, treatment and outcomes. Through her Precision Medicine in Diabetes Consultation Clinic, she partners with patients to personalize therapies and improve quality of life, including for those with rare forms of diabetes.
My endeavor
My endeavor is to improve the lives of people with diabetes and cardiometabolic disease by advancing care through research on new treatments and technologies.
Care philosophy
I believe every visit is a chance to reassess and optimize care. Whether it’s through genetic testing or the latest technology, I work with my patients to identify options that are right for them. I’m especially committed to helping those with diabetes feel empowered, informed and hopeful about what’s possible.
Overview
- Gender Female
Conditions treated (4)
- Type 1 diabetes
- Type 2 diabetes
- Atypical diabetes
- Monogenic Diabetes (e.g. MODY)
Treatments offered (2)
- Genetic testing to look for underlying genetic causes for atypical forms of diabetes
- Maturity-onset diabetes of the young (MODY) or unclear type of diabetes
-
Endeavor Health Medical Group
9977 Woods Dr., Suite 300 Skokie, IL 60077-1057
-
2004University of Illinois at Chicago College of Medicine
-
2007Internal MedicineMcGaw Medical Center of Northwestern University
-
2008EndocrinologyMcGaw Medical Center of Northwestern University
-
2011EndocrinologyMassachusetts General Hospital
-
2010Endocrinology, Diabetes & MetabolismAmerican Board of Internal Medicine
-
Clinical Associate Professor, The University of Chicago Pritzker School of Medicine
Pharmaceutical, device, and biotechnology companies frequently collaborate with research scientists and physicians to help advance scientific knowledge and improve patient care. These relationships can support scientific breakthroughs and help establish the effectiveness and safety of promising new therapies.
To ensure objectivity in clinical research and patient care, Endeavor Health maintains integrity policies requiring researchers and clinicians — whether in full-time, part-time and unpaid or voluntary roles — to disclose compensated and uncompensated relationships with external industry organizations.
Patients are encouraged to discuss these relationships with their physician as well as to inquire as to how these relationships are overseen by Endeavor Health. Learn more about our Conflict of Interest and Commitment Policy.
Additionally, patients can visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website, a national disclosure program that promotes a more transparent and accountable healthcare system. It houses a publicly accessible database of payments that reporting entities — including pharmaceutical, device, and biotechnology companies — make to covered recipients such as physicians and hospitals.
CMS is required by law to publish this data annually on or before June 30 for the previous reporting year. The data is published annually, so it may not reflect the most recent reporting period. If you have questions about the information, talk with your physician.
More about Dr. Billings
